Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,799 public trials 831 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19

NCT04922788

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations: Military Medical Academy Hanoi, Vietnam

View Trial Details

Completed

The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)

NCT01327651

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Harlem Prevention Center CRS New York, United States

Emavundleni CRS Cape Town, Western Cape, South Africa

Silom Community Clinic CRS Nonthaburi, Thailand

View Trial Details

Completed

Eccentric Cycling Vs. Standard Rehabilitation for Post-ICU Recovery in COVID-19 Survivors

NCT06895850

Conditions: COVID 19, COVID-19, Coronaviridae Infections, +10 more
Locations: Universidad Andres Bello Santiago, Santiago Metropolitan, Chile

View Trial Details

Completed

A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya

NCT04826094

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Kenya Medical Research Institute/Walter Reed Project, Clinical Research Centre, Off Hospital Road Kericho, Kenya

View Trial Details

Completed

A Cross-sectional, Observational Study to Characterise Long COVID-19 in an Urban Sample of South African Adults

NCT05445713

Conditions: COVID-19, Chronic Disease, Coronaviridae Infections, +16 more
Locations: Sunnyside Office Park Johannesburg, Gauteng, South Africa

Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) Johannesburg, Gauteng, South Africa

View Trial Details

Completed

Influenza Vaccine Elicited Immune Response in Immunocompromised Patients

NCT06738082

Conditions: Immunocompromised Patients, Infections, Influenza Vaccine, +6 more
Locations: Universitsy Hospital Bern Bern, Switzerland

View Trial Details

Completed

The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients

NCT04884490

Conditions: COVID-19, COVID-19 Pneumonia, Coronaviridae Infections, +10 more
Locations: Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh

View Trial Details

Completed

MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004)

NCT05494736

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: ARENSIA Exploratory Medicine-Institutul National de Boli Infectioase Matei Bals ( Site 0004) Bucharest, Romania

Josha Research ( Site 0003) Bloemfontein, Free State, South Africa

Helen Joseph Hospital-Clinical HIV Research Unit ( Site 0002) Johannesburg, Gauteng, South Africa

Desmond Tutu Health Foundation ( Site 0001) Cape Town, Western Cape, South Africa

View Trial Details

Completed

Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)

NCT04478071

Conditions: Acute Respiratory Distress Syndrome, COVID-19, Coronaviridae Infections, +13 more
Locations: The University of Texas Health Science Center at Houston Houston, Texas, United States

View Trial Details

Completed

Hemoperfusion Efferon СT for the Extremely Severe Form of COVID-19

NCT06402279

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations: Alexey Yakovlev Nizhny Novgorod, Russia

View Trial Details

RNA Virus Infections

RNA Virus Infections trial results

Related conditions